Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Changes in Gene Expression during G-CSF-Induced Emergency Granulopoiesis in Humans

Corinna Cavan Pedersen, M.Sc. Eng., Rehannah Borup, M.Sc., Anne Fischer-Nielsen, MD PhD, Helena Mora-Jensen, PhD, Anna Fossum, M.Sc., Jack B. Cowland, Niels Borregaard

Blood (2015) 126 (23): 2202.

https://doi.org/10.1182/blood.V126.23.2202.2202

Published: 2015

Journal Articles

The Bruton Tyrosine Kinase (BTK) Inhibitor ACP-196 Demonstrates Clinical Activity in Two Mouse Models of Chronic Lymphocytic Leukemia

Sarah E. M. Herman, PhD, Arnau Montraveta, BS, Carsten U Niemann, MD PhD, Helena Mora-Jensen, PhD, Michael Gulrajani, BS, Fanny Krantz, Bonnie K. Harrington, DVM, Todd Covey, Brian J Lannutti, PhD, Raquel Izumi, PhD, Roger G Ulrich, PhD, John C. Byrd, MD, Adrian Wiestner, MD PhD, Amy J. Johnson, PhD, Jennifer A. Woyach, MD

Blood (2015) 126 (23): 2920.

https://doi.org/10.1182/blood.V126.23.2920.2920

Published: 2015

Journal Articles

miRNA-130a regulates C/EBP-ε expression during granulopoiesis

Maria T. Larsen, Mattias Häger, Andreas Glenthøj, Fazila Asmar, Stine N. Clemmensen, Helena Mora-Jensen, Niels Borregaard, Jack B. Cowland

Blood (2014) 123 (7): 1079–1089.

https://doi.org/10.1182/blood-2013-08-523233

Published: 2014

Includes: Supplemental data

Journal Articles

Comparing cancer vs normal gene expression profiles identifies new disease entities and common transcriptional programs in AML patients

Nicolas Rapin, Frederik Otzen Bagger, Johan Jendholm, Helena Mora-Jensen, Anders Krogh, Alexander Kohlmann, Christian Thiede, Niels Borregaard, Lars Bullinger, Ole Winther, Kim Theilgaard-Mönch, Bo T. Porse

Blood (2014) 123 (6): 894–904.

https://doi.org/10.1182/blood-2013-02-485771

Published: 2014

Includes: Supplemental data

Journal Articles

Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation

Patricia Pérez-Galán, Helena Mora-Jensen, Marc A. Weniger, Arthur L. Shaffer, III, Edgar G. Rizzatti, Colby M. Chapman, Clifton C. Mo, Lawrence S. Stennett, Christoph Rader, Poching Liu, Nalini Raghavachari, Maryalice Stetler-Stevenson, Constance Yuan, Stefania Pittaluga, Irina Maric, Kieron M. Dunleavy, Wyndham H. Wilson, Louis M. Staudt, Adrian Wiestner

Blood (2011) 117 (2): 542–552.

https://doi.org/10.1182/blood-2010-02-269514

Published: 2011

Includes: Supplemental data

Journal Articles

Olfactomedin 4, An Indicator of the Existence of Neutrophil Subsets.

Stine Novrup Clemmensen, Sara Roervig, Jonathan Wren, PhD, Martin Illemann, PhD, Andreas Glenthoj, Helena Mora-Jensen, Elisabeth Cramer, Maria Torp Larsen, Lars C. Jacobsen, Jack B Cowland, MS, PhD, Niels Borregaard, MD, PhD

Blood (2010) 116 (21): 3775.

https://doi.org/10.1182/blood.V116.21.3775.3775

Published: 2010

Journal Articles

Bortezomib Resistance in Mantle Cell Lymphoma Is Associated with Expression of a Plasmacytoid Differentiation Program.

Patricia Perez Galan, PhD, Helena Mora Jensen, Marc A Weniger, PhD, Colby M Chapman, Poching Liu, PhD, Nalini Raghavachari, PhD, Arthur L Shaffer, III, PhD, Louis M. Staudt, MD, PhD, Adrian Wiestner, MD, PhD

Blood (2009) 114 (22): 287.

https://doi.org/10.1182/blood.V114.22.287.287

Published: 2009

Journal Articles

Resistance to Bortezomib Develops Slowly in MCL Cells, Extends to the Class of Proteasome Inhibitors, and Is Associated with Decreased Proliferation of the Resistant Cells.

Helena Mora-Jensen, BS, Edgar G. Rizzatti, MD,PhD, Adrian Wiestner, MD,PhD

Blood (2006) 108 (11): 4397.

https://doi.org/10.1182/blood.V108.11.4397.4397

Published: 2006

Journal Articles

Bortezomib Activity Against Mantle Cell Lymphoma Overcomes Classic Mechanisms of Drug Resistance and Targets Cell Cycle Control.

Edgar G. Rizzatti, MD, PhD, Helena Mora-Jensen, BS, Elinor Lee, BS, Yuji Miura, MD/PhD, Raymond Lai, MD/PhD, Masanori Daibata, MD, Adrian Wiestner, MD/PhD

Blood (2006) 108 (11): 4393.

https://doi.org/10.1182/blood.V108.11.4393.4393

Published: 2006

Journal Articles

Bortezomib Induces an Antioxidant and ER-Stress Response Gene Expression Signature in Mantle Cell Lymphoma: Implications for Response Prediction and Optimized Chemotherapy Regimens.

Edgar G. Rizzatti, MD, PhD, Helena Mora-Jensen, BS, Raymond Lai, MD/PhD, Masanori Daibata, MD, Therese White, RN, Kieron Dunleavy, MD, Wyndham Wilson, MD/PhD, Adrian Wiestner, MD/PhD

Blood (2006) 108 (11): 830.

https://doi.org/10.1182/blood.V108.11.830.830

Published: 2006

NARROW

Changes in Gene Expression during G-CSF-Induced Emergency Granulopoiesis in Humans

The Bruton Tyrosine Kinase (BTK) Inhibitor ACP-196 Demonstrates Clinical Activity in Two Mouse Models of Chronic Lymphocytic Leukemia

miRNA-130a regulates C/EBP-ε expression during granulopoiesis

Comparing cancer vs normal gene expression profiles identifies new disease entities and common transcriptional programs in AML patients

Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation

Olfactomedin 4, An Indicator of the Existence of Neutrophil Subsets.

Bortezomib Resistance in Mantle Cell Lymphoma Is Associated with Expression of a Plasmacytoid Differentiation Program.

Resistance to Bortezomib Develops Slowly in MCL Cells, Extends to the Class of Proteasome Inhibitors, and Is Associated with Decreased Proliferation of the Resistant Cells.

Bortezomib Activity Against Mantle Cell Lymphoma Overcomes Classic Mechanisms of Drug Resistance and Targets Cell Cycle Control.

Bortezomib Induces an Antioxidant and ER-Stress Response Gene Expression Signature in Mantle Cell Lymphoma: Implications for Response Prediction and Optimized Chemotherapy Regimens.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only